FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes a preparation possessing anti-arrhythmic activity that represents nonpeptide antagonist of opioid receptors naltrindol. Naltrindol showed the expressed anti-arrhythmic effect in model of ischemic and reperfusion arrhythmia.
EFFECT: valuable medicinal property of agent.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-ARRHYTHMIC AGENT | 2004 |
|
RU2260442C1 |
ANTI-ARRHYTHMIC AGENT | 2003 |
|
RU2235553C1 |
AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
ANTI-ARRHYTHMIC AGENT | 2001 |
|
RU2195275C1 |
CARDIOTONIC PREPARATION | 1998 |
|
RU2163817C2 |
PREPARATION FOR TREATING ARRHYTHMIA | 1998 |
|
RU2163807C2 |
AGENT SIMULATING CARDIAC POSTCONDITIONING PHENOMENON | 2012 |
|
RU2502508C1 |
AGENT IMPROVING BLOOD SUPPLY AND MYOCARDIAL METABOLISM | 2002 |
|
RU2225201C2 |
ANTIARRHYTHMIC AGENT | 1998 |
|
RU2171115C2 |
AGENT IMPROVING CARDIAC RESISTANCE TO ISCHEMIC AND FOLLOWING REPERFUSION INJURIES | 2012 |
|
RU2488404C1 |
Authors
Dates
2008-03-27—Published
2005-07-27—Filed